Literature DB >> 12088352

Hereditary colorectal cancer: keeping it in the family--the bowel cancer story.

D R McGrath1, A D Spigelman.   

Abstract

Up to 20% of colorectal cancers are thought to have a genetic component. Several familial syndromes are known to confer an increased risk for colorectal cancer. Advances in our understanding of these syndromes has improved the care delivered to, and the overall survival of, these patients. Genetic testing has great potential to further improve detection and direct subsequent preventative measures. The diagnosis, management and surveillance issues relating to some of the more commonly encountered syndromes - in particular Familial Adenomatous Polyposis and Hereditary Non-Polyposis Colorectal Cancer - are reviewed.

Entities:  

Mesh:

Year:  2002        PMID: 12088352     DOI: 10.1046/j.1445-5994.2002.00224.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

1.  In the beginning there was colectomy: current surgical options in familial adenomatous polyposis.

Authors:  Daniel R McGrath; Allan D Spigelman
Journal:  Hered Cancer Clin Pract       Date:  2004-11-15       Impact factor: 2.857

2.  People with low serum folate levels have higher risk of colorectal adenoma/advanced colorectal adenoma occurrence and recurrence in China.

Authors:  Hui Ding; Qin-Yan Gao; Hui-Min Chen; Jing-Yuan Fang
Journal:  J Int Med Res       Date:  2016-06-29       Impact factor: 1.671

3.  Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability.

Authors:  In Ja Park; Hee Cheol Kim; Yong Sik Yoon; Chang Sik Yu; Se Jin Jang; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

4.  CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria.

Authors:  Hee Cheol Kim; Hyeon Jung Lee; Seon Ae Roh; Jung-Sun Kim; Chang Sik Yu; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2008-04       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.